These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3937060)

  • 21. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
    Ogawa N; Kuroda H; Yamamoto M; Nukina I; Ota Z
    Acta Med Okayama; 1984 Jun; 38(3):301-4. PubMed ID: 6431755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
    Harada H; Noto T; Tsuji M; Taga C; Hashimoto H; Nakajima T
    Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
    Hirose A; Sasa M; Ohno Y; Takaori S
    Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G; Holmes C; Sullivan P; Goldstein DS
    Clin Auton Res; 2019 Feb; 29(1):113-117. PubMed ID: 30229336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of L-erythro-3, 4-dihydroxyphenylserine on sleep-wakefulness patterns and concentrations of brain catecholamines and serotonin in rats.
    Mori M; Hashimoto H; Fukui K; Mori T; Noto T; Nakajima T
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):301-10. PubMed ID: 3125374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further evidence of the dual role of noradrenaline in regulation of thyrotrophin secretion in male rats.
    Männistö PT; Mattila J; Tuomisto J
    Acta Endocrinol (Copenh); 1981 Jun; 97(2):213-20. PubMed ID: 7234288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S; Oyabe A; Tanno M; Suzuki-Kusaba M
    Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An L-DOPA-like depressor action of L-threo-dihydroxyphenyl-serine in the rat caudal ventrolateral medulla.
    Furukawa N; Goshima Y; Miyamae T; Nishihama M; Okumura F; Fujita K; Misu Y
    Life Sci; 1997; 61(12):1177-83. PubMed ID: 9315508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
    Ogawa N; Yamamoto M; Takayama H
    J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propranolol-induced seizures in mice: the role of noradrenaline.
    Amabeoku GJ; Syce JA
    Cell Mol Life Sci; 1997 Aug; 53(8):646-51. PubMed ID: 9351467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive chronotropic effect of threo-3,4-dihydroxyphenylserine as a precursor of noradrenaline in rat isolated atria.
    Araki H; Cheng JT; Ohmura I; Tanaka C
    J Pharm Pharmacol; 1978 Jul; 30(7):456-8. PubMed ID: 27618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.